Several cytokines have been investigated as potential treatment to treat GBM, such as IFN-α, TGF-β, IL-2, IL-12, etc. A clinical trial investigated the efficacy of combining temozolomide with IFN-α compare to temozolomide monotherapy in nGBM (51). Here, IL2 is linked to glioblastoma.